Translumina Therapeutics is an India-based medical device company specializing in cardiovascular and endovascular products. Founded in 2008, it focuses on innovation-driven development of stents and catheters for interventional cardiology applications.
The company offers coronary stents, balloon catheters and vascular intervention devices. Its solutions are designed for clinical performance, safety and affordability, serving both domestic and international healthcare markets.
Sustainability efforts include ethical manufacturing, regulatory compliance and patient-focused innovation. The company emphasizes quality systems, responsible sourcing and governance practices aligned with global medical device standards.
Translumina Therapeutics exports to over 50 countries with regulatory approvals across multiple regions. Its global footprint includes distributors and partnerships supporting international market access.
Further Details
Some additional details about the company are listed below:
| Parameter | Details |
|---|---|
| Translumina Therapeutics | https://www.translumina.com/ |
| Company Name | Translumina Therapeutics |
| Application Areas | Cardiology and vascular interventions |
| Sustainability Recognition | Ethical healthcare manufacturing practices |
| Key Technologies | Stent engineering, polymer coating, catheter systems |
| Industry | Cardiovascular medical devices |
| Core Focus | Interventional cardiology solutions |
| Solutions Offered | Drug-eluting stents, balloons, access devices |